Severe CIDP-MGUS responsive to Rituximab

Chronic inflammatory demyelinating polyneuropathy (CIDP) is a relatively rare disease with progressive limb weakness and sensory loss. A few patients show a severely progressing course without major response to intravenous immunoglobulin or plasma exchange therapy. CIDP-MGUS (monoclonal gammopathy o...

Descripción completa

Detalles Bibliográficos
Autores principales: Posa, Andreas, Emmer, Alexander, Kornhuber, Malte
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7306592/
https://www.ncbi.nlm.nih.gov/pubmed/32596526
http://dx.doi.org/10.1016/j.heliyon.2020.e04230

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7306592/
https://www.ncbi.nlm.nih.gov/pubmed/32596526
http://dx.doi.org/10.1016/j.heliyon.2020.e04230

Ejemplares similares